Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. [PDF]
Zuckerman NS +21 more
europepmc +1 more source
A short review on poliomyelitis: types, transmission, diagnosis, prevention, treatment
This research is focused on the impact of poliomyelitis in current era. It also explores strategies for its prevention and control. The study utilizes qualitative research methods to comprehensively explain and support interpretive goals. Secondary data
Ayna Marzia, Liaqat Ali
doaj +2 more sources
Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference. [PDF]
Islam MT +16 more
europepmc +1 more source
Polio vaccine and retroviruses
In this paper we consider the main steps in the process of manufacture of oral polio vaccine and assess the probable clearance factor for HIV retrovirus at each step.
Florian Horaud, John Beale
core
Oral Polio Vaccine Campaigns May Reduce the Risk of Death from Respiratory Infections. [PDF]
Nielsen S +4 more
europepmc +1 more source
Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau. [PDF]
Fisker AB +7 more
europepmc +1 more source
Time for a Worldwide Shift from Oral Polio Vaccine to Inactivated Polio Vaccine [PDF]
openaire +3 more sources
Emergence of vaccine-derived poliovirus strains from the novel oral polio vaccine in the Central African Republic. [PDF]
Doté JW +9 more
europepmc +1 more source
Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV. [PDF]
Aaby P +9 more
europepmc +1 more source
Effect of BCG Danish and oral polio vaccine on neonatal mortality in newborn babies weighing less than 2000 g in India: multicentre open label randomised controlled trial (BLOW2). [PDF]
Adhisivam B +9 more
europepmc +1 more source

